TickerLeague

Buyback Spend for DexCom (DXCM)

Buyback Spend for DexCom (DXCM): headline value $500.00M · YoY -33.3%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

DexCom, Inc. logo
DexCom

DXCM

Latest period

$500.00M

YoY change

-33.3%

5Y CAGR

N/A

Peak year (2024)

$750.00M

Latest annual

$500.00M

Buyback Spend history chart for DexCom (DXCM) from 2003 to 2025

Buyback Spend history table for DexCom (DXCM) from 2003 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$500.00M-33.3%
2024$750.00M+8.9%
2023$688.70M+23.5%
2022$557.70M
2021$0
2020$0
2019$0-100.0%
2018$100.00M
2017$0
2016$0
2015$0
2014$0
2013$0
2012$0
2011$0
2010$0
2009$0
2008$0-100.0%
2007$2.73M
2006$0
2005$0
2004$0
2003$0

Buyback Spend values are taken from DexCom's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

DexCom (DXCM) most recent annual buyback spend stands at $500.00M (2025) – plunged 33.3% year-over-year.

DexCom buyback spend peaked at $750.00M in 2024; the latest annual figure is $500.00M in 2025 (33.3% below peak).

$750.00M stands as the all-time-high annual buyback spend, posted in 2024, against a low of $0 during 2003.

Among 8 Healthcare peers, DexCom (DXCM) ranks 8th; the peer median for buyback spend is $2.75B.

DexCom Buyback Spend by Year

DexCom Buyback Spend 2025: $500.00M

DexCom buyback spend in 2025 was $500.00M, plunged 33.3% below 2024.

DexCom Buyback Spend 2024: $750.00M

DexCom buyback spend in 2024 was $750.00M, grew 8.9% from 2023. This figure represents the highest annual value in the available history.

DexCom Buyback Spend 2023: $688.70M

DexCom buyback spend in 2023 was $688.70M, grew 23.5% from 2022.

DexCom Buyback Spend 2022: $557.70M

DexCom buyback spend in 2022 was $557.70M.

DexCom Buyback Spend 2021: $0

DexCom buyback spend in 2021 was $0.

See more financial history for DexCom (DXCM).

Sector peers — Buyback Spend

Companies in the same sector as DexCom, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AbbVie Inc. (ABBV)$980.00MHealthcare
AstraZeneca PLC (AZN)$719.66MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is DexCom's buyback spend?

Latest reported buyback spend for DexCom (DXCM) is $500.00M (period ending December 31, 2025).

How has DexCom buyback spend changed year-over-year?

DexCom (DXCM) buyback spend changed -33.3% year-over-year on the latest annual filing.

When did DexCom buyback spend hit its highest annual value?

DexCom buyback spend reached its highest annual value of $750.00M in 2024.

What was DexCom buyback spend in 2024?

DexCom (DXCM) buyback spend in 2024 was $750.00M.

What was DexCom buyback spend in 2025?

DexCom (DXCM) buyback spend in 2025 was $500.00M.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.